Top Markets
#1 Velas Velas +367.73%
#2 Gravity Gravity +48.81%
#3 Galxe Galxe +41.61%
#4 Infinity Ground Infinity Ground +30.19%
#5 Audiera Audiera +29.99%
#6 Fetch.ai Fetch.ai +26.67%
#7 Derive Derive +25.50%
#8 Wiki Cat Wiki Cat +25.33%
#9 Aria.AI Aria.AI +20.16%
#10 Fuzzybear Fuzzybear +18.58%
Coin of the day
Velas Velas
설정
언어
한국어
통화
USD
테마
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
주식 순위 #96
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
주가
$38.41
시가총액
$170.67B
변동 (1일)
1.17%
변동 (1년)
-49.92%
국가
DK
거래 Novo Nordisk A/S (NVO)

카테고리

Healthcare
시가총액
수익
더 보기
수익금
가격 기록
P/E 비율
P/S 비율
P/B 비율
영업 이익률
EPS
주식 분할
배당금
배당 수익률
발행 주식 수
Novo Nordisk A/S (NVO)의 주가 이력
최고 종가: $38.35 (2026-03-01 기준)

최저 종가: $28.10 (2007-07-01 기준)
Novo Nordisk A/S의 주가 이력 (2007 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 17.70%
2025 -51.54%
2024 1.70%
2023 -23.31%
2022 17.33%
2021 57.90%
2020 22.89%
2019 26.29%
2018 -13.92%
2017 49.77%
2016 -37.97%
2015 26.27%
2014 24.70%
2013 10.84%
2012 43.58%
2011 6.03%
2010 -4.61%
2009 14.74%
2008 -41.68%
2007 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $465.49 -7.78%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $755.73 13.32%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $302.35 54.55%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $99.21 -36.97%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $703.96 16.36%
NL